Literature DB >> 3366157

Clinical pharmacology in Europe: an indispensible part of the health service. WHO Working Group on Clinical Pharmacology in Europe.

.   

Abstract

Mesh：

Year:  1988        PMID： 3366157     DOI： 10.1007/bf00542483

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  8 in total

1.  Problem-oriented drug information: a clinical pharmacological service.

Authors:  G Alván; B Ohman; F Sjöqvist
Journal:  Lancet       Date:  1983-12-17       Impact factor: 79.321

2.  What therapeutic drugs should be monitored?

Authors: 
Journal:  Lancet       Date:  1985-08-10       Impact factor: 79.321

Review 3.  Tricyclic antidepressants--blood level measurements and clinical outcome: an APA Task Force report. Task Force on the Use of Laboratory Tests in Psychiatry.

Authors: 
Journal:  Am J Psychiatry       Date:  1985-02       Impact factor: 18.112

4.  Postgraduate education in therapeutics: experience in Merseyside.

Authors:  A Breckenridge; M Orme; M J Serlin; A S Davidson; J F Lowe
Journal:  Br Med J       Date:  1978-09-02

Review 5.  Defective oxidation of drugs: pharmacokinetic and therapeutic implications.

Authors:  M Eichelbaum
Journal:  Clin Pharmacokinet       Date:  1982 Jan-Feb       Impact factor: 6.447

6.  Postmarketing surveillance of adverse reactions to drugs.

Authors:  M D Rawlins
Journal:  Br Med J (Clin Res Ed)       Date:  1984-03-24

7.  Drug-related problems causing admission to a medical clinic.

Authors:  U Bergman; B E Wiholm
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

8.  Clinical pharmacology scope, organization, training. Report of a WHO study group.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1970
  8 in total
  10 in total

1.  Therapeutic consultation centres are helpful in developing countries.

Authors:  Albert Figueras; Joan-Ramon Laporte
Journal:  BMJ       Date:  2002-01-26

2.  Clinical pharmacology and the provision of drug information.

Authors:  B Ohman; H Lyrvall; E Törnqvist; G Alván; F Sjöqvist
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

3.  Clinical pharmacology in Europe. The WHO European Task Force on Clinical Pharmacology.

Authors:  M Orme; F Sjöqvist
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 4.  Therapeutic drug monitoring beyond 2000.

Authors:  G M Shenfield
Journal:  Br J Clin Pharmacol       Date:  1998-08       Impact factor: 4.335

5.  References used in a drug information centre.

Authors:  A Llerena; B Ohman; G Alván
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

6.  The teaching and organisation of clinical pharmacology in European medical schools (W.H.O. Working Group on Clinical Pharmacology).

Authors:  M Orme; F Sjoqvist; J Bircher; M Bogaert; M N Dukes; M Eichelbaum; L F Gram; H Huller; I Lunde; G Tognoni
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

7.  Clinical pharmacology and primary health care in Europe--a gap to bridge. The WHO Working Group on Clinical Pharmacology in Europe.

Authors:  G Dukes; P K Lunde; A Melander; M Orme; F Sjöqvist; G Tognoni; H Wesseling
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

8.  Clinical pharmacology in everyday clinical care.

Authors:  Petra A Thürmann
Journal:  Eur J Clin Pharmacol       Date:  2013-05-03       Impact factor: 2.953

9.  Comparison of rational pharmacotherapy decision-making competence of general practitioners with intern doctors.

Authors:  A Akici; S Kalaça; M Z Gören; A G Akkan; A Karaalp; D Demir; U Uğurlu; S Oktay
Journal:  Eur J Clin Pharmacol       Date:  2004-03-20       Impact factor: 2.953

10.  Teaching clinical pharmacology and therapeutics with an emphasis on the therapeutic reasoning of undergraduate medical students.

Authors:  Milan C Richir; Jelle Tichelaar; Eric C T Geijteman; Theo P G M de Vries
Journal:  Eur J Clin Pharmacol       Date:  2008-01-29       Impact factor: 2.953
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.